Citations

Showing 10 of 108083 citations.

Human Airway Basal Cells Undergo Reversible Squamous Differentiation and Reshape Innate Immunity
Black, Katharine E., Phung, Thien‐Khoi N. , Thundivalappil, Sujatha, Xu, Jie , Lapey, Allen , Lerou, Paul H. , Que, Jianwen, Park, Jin‐Ah , Hurley, Bryan P. , Mou, Hongmei , Que, Jianwen , Mou, Hongmei , Park, Jin-Ah , Que, Jianwen , Zhang, Yihan , Lin, Tian , Wang, Wei , Zhang, Cheng , Hariri, Lida P. , Li, Hu , Ai, Xingbin

Mayo Clinic

American Journal of Respiratory Cell and Molecular Biology | February 8, 2023 | Volume: 68 | Issue: 6 | Pages: 664-678

10.1165/rcmb.2022-0299oc | PMID 36753317 Get It

Abstract Histological and lineage immunofluorescence examination revealed that healthy conducting airways of humans and animals harbor sporadic poorly differentiated epithelial patches mostly in the dorsal noncartilage regions that remarkably manifest squamous differentiation. In vitro analysis demonstrated that this squamous phenotype is not due to intrinsic functional change in underlying airway basal cells. Rather, it is a reversible physiological response to persistent Wnt signaling stimulation during de novo differentiation. Squamous epithelial cells have elevated gene signatures of glucose uptake and cellular glycolysis. Inhibition of glycolysis or a decrease in glucose availability suppresses Wnt-induced squamous epithelial differentiation. Compared with pseudostratified airway epithelial cells, a cascade of mucosal protective functions is impaired in squamous epithelial cells, featuring increased epithelial permeability, spontaneous epithelial unjamming, and enhanced inflammatory responses. Our study raises the possibility that the squamous differentiation naturally occurring in healthy airways identified herein may represent “vulnerable spots” within the airway mucosa that are sensitive to damage and inflammation when confronted by infection or injury. Squamous metaplasia and hyperplasia are hallmarks of many airway diseases, thereby expanding these areas of vulnerability with potential pathological consequences. Thus, investigation of physiological and reversible squamous differentiation from healthy airway basal cells may provide critical knowledge to understand pathogenic squamous remodeling, which is often nonreversible, progressive, and hyperinflammatory.
State of the art review: The management of chronic vascular disorders in the hand and upper limb
Titan, Ashley L. , Chang, James, Murray, Peter M. , Hammert, Warren C. , Murray, Peter, Hammert, Warren , Megerle, Kai

Mayo Clinic

Journal of Hand Surgery (European Volume) | February 8, 2023 | Volume: 48 | Issue: 4 | Pages: 295-302

10.1177/17531934221145498 | PMID 36753288 Get It

This review article summarizes the basic principles of vascular anatomy, physiology, diagnostic work-up and treatment for patients with nontraumatic upper extremity vascular disorders. Vascular disorders can be considered vasospastic or occlusive. The most commonly encountered vasospastic condition is Raynaud’s Phenomenon secondary to scleroderma. While historically this has been managed medically with vasodilators, more advanced cases can benefit from surgical treatment to improve blood flow and minimize tissue loss, with compelling evidence that earlier surgical intervention can modify disease process and should be considered. Occlusive disease can present as aneurysm or thrombosis and often requires surgical treatment with resection of the occluded segment with or without vascular reconstruction. In advanced atherosclerotic disease or end stage ischemia, arterialization of the venous system can be considered to avoid more proximal amputations.
Evaluation of Associations of Growth Differentiation Factor-11, Growth Differentiation Factor-8, and Their Binding Proteins, Follistatin and Follistatin-Like Protein-3, With Measures of Skeletal Muscle Mass, Muscle Strength, and Physical Function in Older
Cawthon, Peggy M. , Patel, Sheena, Bhasin, Shalender , Peng, Liming , Lee, Se‐Jin , Ferrucci, Luigi , Ganz, Peter , Cummings, Steven R. , Newman, Anne B. , Bhasin, Shalinder , Ferrucci, Luigi , Ganz, Peter , Cawthon, Peggy , Tracy, Russell P. , Kizer, Jorge R. , LeBrasseur, Nathan K.

Mayo Clinic

The Journals of Gerontology: Series A | February 8, 2023 | Volume: 78 | Issue: 11 | Pages: 2051-2059

10.1093/gerona/glad045 | PMID 36752218 Get It

Abstract Background Based on studies from animal models, growth differentiation factor-11 (GDF-11) may have rejuvenating effects in humans. GDF-11 has high sequence homology with GDF-8 (also known as myostatin); follistatin and follistatin-like protein-3 (FSTL-3) are inhibitory proteins of both GDF-8 and GDF-11. Methods Using highly specific liquid chromatography with tandem mass spectrometry assays for GDF-11 and GDF-8 and immunoassays for follistatin and FSTL-3, we quantified the association of these factors with muscle size, strength, and physical performance in 2 prospective cohort studies of community-dwelling older adults (Health, Aging, and Body Composition study [Health ABC] and Cardiovascular Health Study [CHS]). Results GDF-8 levels were positively associated with thigh muscle cross-sectional area and density in Health ABC (data not available in CHS). GDF-8 levels were positively associated with lean mass (a surrogate of muscle mass) in Health ABC but not CHS, and grip strength in CHS but not Health ABC. FSTL-3 (and perhaps follistatin) was negatively associated with lean mass and had variable associations with other variables. In contrast, GDF-11 was not significantly associated with strength or performance. Conclusions GDF-8 and its binding proteins, follistatin and FSTL-3, may constitute a counterregulatory system (chalones) to restrain age-related loss of muscle mass and strength.
Griseofulvin Radiosensitizes Non–Small Cell Lung Cancer Cells and Activates cGAS
Wang, Xing , Raman, Natasha , Lemtiri-Chlieh, Ghali , Chang, Jinhee , Jagtap, Shreya , Chowdhury, Dipanwita D. , Ballew, Matthew , Carrieri, Francesca A. , Nguyen, Triet , Nugent, Katriana , Peck, Travis , Levine, Michelle S. , Chan, Aaron , Lam, Christine , Malek, Reem , Hoang, Tung , Phillips, Ryan , Cheng, Zhuoan , Taparra, Kekoa , Connis, Nick , Hann, Christine L. , Holland, Andrew J. , Lafargue, Audrey , Chowdhury, Dipanwita Dutta , Carrieri, Francesca Anna , Holland, Andrew , Tran, Phuoc T , Lafargue, Audrey , Wang, Hailun , Peck, Travis

Mayo Clinic

Molecular Cancer Therapeutics | February 8, 2023 | Volume: 22 | Issue: 4 | Pages: 519-528

10.1158/1535-7163.mct-22-0191 | PMID 36752776 Get It

Abstract Extra copies of centrosomes are frequently observed in cancer cells. To survive and proliferate, cancer cells have developed strategies to cluster extra-centrosomes to form bipolar mitotic spindles. The aim of this study was to investigate whether centrosome clustering (CC) inhibition (CCi) would preferentially radiosensitize non–small cell lung cancer (NSCLC). Griseofulvin (GF; FDA-approved treatment) inhibits CC, and combined with radiation treatment (RT), resulted in a significant increase in the number of NSCLC cells with multipolar spindles, and decreased cell viability and colony formation ability in vitro. In vivo, GF treatment was well tolerated by mice, and the combined therapy of GF and radiation treatment resulted in a significant tumor growth delay. Both GF and radiation treatment also induced the generation of micronuclei (MN) in vitro and in vivo and activated cyclic GMP-AMP synthase (cGAS) in NSCLC cells. A significant increase in downstream cGAS-STING pathway activation was seen after combination treatment in A549 radioresistant cells that was dependent on cGAS. In conclusion, GF increased radiation treatment efficacy in lung cancer preclinical models in vitro and in vivo. This effect may be associated with the generation of MN and the activation of cGAS. These data suggest that the combination therapy of CCi, radiation treatment, and immunotherapy could be a promising strategy to treat NSCLC.
Procalcitonin as a biomarker for predicting bacterial infection in chimeric antigen receptor T‐cell therapy recipients
Powell, Marissa , Mara, Kristin C. , Bansal, Radhika , Hathcock, Matthew , Khurana, Arushi , Bennani, N. Nora , Wang, Yucai , Villasboas, José C. , Ansell, Stephen M. , Johnston, Patrick B. , Barreto, Jason N. , Powell, Marissa Z , Paludo, Jonas , Villasboas, Jose Caetano , Barreto, Jason N , Bennani, N Nora , Wang, Yucai , Mara, Kristin C , Paludo, Jonas , Lin, Yi

Mayo Clinic

Cancer Medicine | February 8, 2023 | Volume: 12 | Issue: 8 | Pages: 9228-9235

10.1002/cam4.5665 | PMID 36752185 Get It

AbstractBackgroundIt is unknown whether serum procalcitonin (PCT) concentration monitoring can differentiate between bacterial infection or cytokine release syndrome (CRS) when chimeric antigen receptor T‐cell (CAR‐T) recipients present with a constellation of signs and symptoms that may represent both complications.ObjectiveThe objective of the study was to assess the utility of serum PCT concentrations as a biomarker of bacterial infection in CAR‐T recipients.Study designThis single‐center, retrospective, medical record review evaluated patients prescribed CAR‐T therapy until death or 30 days after infusion. Logistic regression modeling determined the association between elevated serum PCT concentrations within 48 h of fever onset and microbiologically confirmed infection. Secondary outcomes included clinically suspected infection, CAR‐T toxicity rates, and broad‐spectrum antibiotic usage. Predictive performance of PCT was assessed by area under the receiver operating characteristic curve (AUC).ResultsThe 98 included patients were a median age of 63 (IQR: 55–69) years old, 47 (48%) were male, and 87 (89%) were Caucasian. Baseline demographics and clinical characteristics were similar between patients with and without a bacterial infection. Serum PCT >0.4 ng/mL within 48 h of fever was significantly associated with a microbiologically confirmed bacterial infection (OR: 2.75 [95% CI: 1.02–7.39], p = 0.045). Median PCT values in patients with and without confirmed infections were 0.40 ng/mL (IQR: 0.26, 0.74) and 0.26 ng/mL (IQR: 0.13, 0.47), respectively. The AUC for PCT to predict bacterial infection was 0.62 (95% CI 0.48–0.76). All patients experienced CRS of some grade, with no difference in CRS severity based on elevated PCT. Broad‐spectrum antibiotics were used for a median of 45% and 23% of days in those with and without confirmed infection, respectively (p = 0.075).ConclusionElevated serum PCT concentrations above 0.4 ng/mL at time of first fever after CAR‐T infusion was significantly associated with confirmed bacterial infection. Furthermore, rigorous, prospective studies should validate our findings and evaluate serial PCT measurements to optimize antimicrobial use after CAR‐T therapy.
Patient preferences for attributes of injected or infused preventive migraine medications: Findings from a discrete choice experiment
Martin, Ashley , Kymes, Steven , Talon, Brian , Lee, Xin Ying , Cady, Roger , Asher, Divya , Karnik‐Henry, Meghana , Mulvihill, Emily , Bates, Dawn, Beusterien, Kathleen , Martin, Ashley , Lee, Xin Ying , Asher, Divya , Schwedt, Todd J.

Mayo Clinic

Headache: The Journal of Head and Face Pain | February 8, 2023 | Volume: 63 | Issue: 4 | Pages: 484-493

10.1111/head.14476 | PMID 36753057 Get It

Abstract Objective To assess preferences among adults with migraine for differentiating attributes of injected or infused preventive treatment options and evaluate their importance in determining a treatment choice. Background Adults with migraine and health‐care providers consider many factors when making treatment decisions. Injected or infused preventive migraine treatment options differ in several attributes, including mode of administration and dosing frequency, which may be preferentially selected or avoided by patients. Understanding a patient's preference is important for clinicians as they advise on various treatment options. Methods A total of 604 US adults diagnosed with migraine participated in an online survey that captured information on demographics, migraine history, and treatment preferences. A discrete choice experiment (DCE) was used to evaluate participants’ preferences for specific attributes of injected/infused preventive migraine therapies. The DCE data were utilized to estimate attribute importance (expressed as a percentage) and identify subgroups that had different distributions of preferences. Results In the overall migraine population, mode of administration (28.8%), durability of effectiveness (27.0%), and speed of onset (25.5%) had the highest relative importance, whereas administration setting (9.9%) and dosing frequency (8.8%) had the lowest. Four distinct subgroups were identified: Group 1 ( n = 128) preferred self‐injection administration and durability of effectiveness; Group 2 ( n = 189) expressed aversion to cranial injections; Group 3 ( n = 158) prioritized rapid speed of onset; and Group 4 ( n = 129) favored health‐care provider administration and durability of effectiveness. Conclusions Speed of onset, durability of effectiveness, and mode of administration are key moderators of treatment preference among US adults with migraine. Certain segments of the migraine population prioritize specific treatment attributes over others, with intravenous infusion not considered a barrier in three of four identified segments. Clinicians can best help their patients find the right medication if they understand which medication attributes are most and least important to them.
Imaging of Small-Bowel Neuroendocrine Neoplasms: AJR Expert Panel Narrative Review
Navin, Patrick J. , Ehman, Eric C. , Liu, Jason B. , Gupta, Akshya , Laghi, Andrea , Yoo, Don C. , Schima, Wolfgang , Sheedy, Shannon P. , Navin, Patrick , Hálfdánarson, Þorvarður R. , Carucci, Laura R.

Mayo Clinic

American Journal of Roentgenology | February 8, 2023 | Volume: 221 | Issue: 3 | Pages: 289-301

10.2214/ajr.22.28877 | PMID 36752369 Get It

Can computed tomography replace or supplement autopsy?
Lathrop, Sarah, Wiest, Philip W., Andrews, Sam, Elifritz, Jamie , Price, Janet P., Mlady, Gary, Zumwalt, Ross E., Gerrard, Chandra Y., Poland, Valerie L., Nolte, Kurt B.

Mayo Clinic

Journal of Forensic Sciences | February 8, 2023 | Volume: 68 | Issue: 2 | Pages: 524-535

10.1111/1556-4029.15217 | PMID 36752321 Get It

Abstract Postmortem computed tomography (PMCT) has been integrated into the practice of many forensic pathologists. To evaluate the utility of PMCT in supplementing and/or supplanting medicolegal autopsy, we conducted a prospective double‐blind comparison of abnormal findings reported by the autopsy pathologist with those reported by a radiologist reviewing the PMCT. We reviewed 890 cases: 167 with blunt force injury (BFI), 63 with pediatric trauma (under 5 years), 203 firearm injuries, and 457 drug poisoning deaths. Autopsy and radiology reports were coded using the Abbreviated Injury Scale and abnormal findings and cause of death (COD) were compared for congruence in consensus conferences with novel pathologists and radiologists. Overall sensitivity for recognizing abnormal findings was 71% for PMCT and 74.6% for autopsy. Sensitivities for PMCT/autopsy were 74%/73.1% for BFI, 61.5%/71.4% for pediatric trauma, 84.9%/83.7% for firearm injuries, and 56.5%/66.4% for drug poisoning deaths. COD assigned by reviewing PMCT/autopsy was correct in 88%/95.8% of BFI cases, 99%/99.5% of firearm fatalities, 82.5%/98.5% of pediatric trauma deaths, and 84%/100% of drug poisoning deaths of individuals younger than 50. Both autopsy and PMCT were imperfect in recognizing injuries. However, both methods identified the most important findings and are sufficient to establish COD in cases of BFI, pediatric trauma, firearm injuries and drug poisoning in individuals younger than 50. Ideally, all forensic pathologists would have access to a CT scanner and a consulting radiologist. This would allow a flexible approach that meets the diagnostic needs of each case and best serves decedents' families and other stakeholders.
Four‐dimensional proteomics analysis of human cerebrospinal fluid with trapped ion mobility spectrometry using PASEF
Mun, Dong‐Gi , Budhraja, Rohit , Bhat, Firdous Ahmad , Zenka, Roman M. , Johnson, Kenneth L. , Pandey, Akhilesh , Bhat, Firdous A., Pandey, Akhilesh , Mun, Dong-Gi , Moghekar, Abhay

Mayo Clinic

PROTEOMICS | February 8, 2023 | Volume: 23 | Issue: 10 | Pages: No page available

10.1002/pmic.202200507 | PMID 36752121 Get It

Abstract A quadrupole time‐of‐flight mass spectrometer coupled with a trapped ion mobility spectrometry (timsTOF) operated in parallel accumulation‐serial fragmentation (PASEF) mode has recently emerged as a platform capable of providing four‐dimensional (4D) features comprising of elution time, collision cross section (CCS), mass‐to‐charge ratio, and intensity of peptides. The PASEF mode provides ∼100% ion sampling efficiency both in data‐dependent acquisition (DDA) and data‐independent acquisition (DIA) modes without sacrificing sensitivity. In addition, targeted measurements using PASEF integrated parallel reaction monitoring (PRM) mode have also been described. However, only limited number of studies have used timsTOF for analysis of clinical samples. Although Orbitrap mass spectrometers have been used for biomarker discovery from cerebrospinal fluid (CSF) in a variety of neurological diseases, these Orbitrap‐derived datasets cannot readily be applied for driving experiments on timsTOF mass spectrometers. We generated a catalog of peptides and proteins in human CSF in DDA mode on a timsTOF mass spectrometer and used these data to build a spectral library. This strategy allowed us to use elution times and ion mobility values from the spectral library to design PRM experiments for quantifying previously discovered biomarkers from CSF samples in Alzheimer's disease. When the same samples were analyzed using a DIA approach combined with a spectral library search, a higher number of proteins were identified than in a library‐free approach. Overall, we have established a spectral library of CSF as a resource and demonstrated its utility for PRM and DIA studies, which should facilitate studies of neurological disorders.
The Use of the Piriformis Fossa Radiographic Landmark to Predict “In-Out-In” Placement of the Posterosuperior Femoral Neck Screw
Kuttner, Nicolas P. , Hoggard, Timothy M. , Cancio-Bello, Alexandra , Adams, John D. , Cancio-Bello, Alexandra M, Yuan, Brandon J. , Hidden, Krystin A.

Mayo Clinic

Journal of Orthopaedic Trauma | February 8, 2023 | Volume: 37 | Issue: 7 | Pages: 330-333

10.1097/bot.0000000000002580 | PMID 36750446 Get It

Objectives: To investigate the correlation between a screw's radiographic relationship to the piriformis fossa with position on CT in the clinical setting. Methods: Intraoperative fluoroscopic images of patients treated with cannulated screw fixation of a femoral neck fracture, who also had a postoperative CT scan, were retrospectively evaluated by 4 fellowship-trained orthopaedic trauma surgeons. The posterosuperior screw on the AP fluoroscopic view was determined to be above the piriformis fossa (APF) or below the piriformis fossa (BPF). Using CT scan to determine IOI placement, the ability to predict IOI position based on fluoroscopic imaging was evaluated by calculating accuracy, sensitivity, specificity, and interobserver reliability. Results: 73 patients met inclusion criteria. The incidence of IOI screw placement was 59% on CT evaluation. The use of the PF landmark accurately predicted CT findings in 89% of patients. A screw placed APF was 90% sensitive and 88% specific in predicting cortical breach, with near-perfect interobserver agreement (κ = 0.81). Conclusion: The use of the PF radiographic landmark is highly sensitive and specific in predicting the placement of an IOI posterosuperior femoral neck screw. Level of Evidence: Diagnostic Level II. See Instructions for Authors for a complete description of levels of evidence.